#Neurology8

14 Jul 2026

NFL players more likely to die from brain diseases

A study of nearly 20,000 NFL players found a fourfold increase in deaths from neurodegenerative diseases such as dementia, Parkinson’s disease and ALS. Risk was higher for longer careers and for certain playing positions.

Read

Photo by Robina Weermeijer, Unsplash

25 Jun 2026

Shorter front‑leg stride linked to cognitive decline in older dogs

A study found that cognitive decline in older dogs is linked to shorter front‑limb (thoracic) stride length. The result could help veterinarians detect dementia earlier and monitor a dog’s condition over time.

Level

Read

31 May 2026

Study links autoantibodies to long COVID symptoms

A new study reports that some people with long COVID make autoantibodies that attack brain and nerve tissue. When researchers gave these antibodies to mice, the animals developed pain, fatigue and balance problems similar to patient symptoms.

Level

Read

29 Apr 2026

How chronic itch may link skin disease and depression

People with atopic dermatitis are seven times more likely to develop major depressive disorder. Researchers accept the link but disagree on why; one proposal says repeated itch signals could change brain circuits.

Level

Read

21 Apr 2026

Drugs for Parkinson’s can change gut bacteria

A new study finds that drugs given to boost levodopa can alter the gut microbiome. This change can let certain bacteria break down levodopa in the gut, reducing the drug’s benefit for the brain.

Level

Read

27 Feb 2026

COVID-19 and Flu: Lasting Effects on Lungs and Brain

A mouse study found that even mild COVID-19 or influenza can cause lasting changes in lungs and brain after infection clears. COVID-19 produced unique, persistent brain inflammation and tiny bleeding not seen after influenza.

Level

Read

30 Dec 2025

Hand numbness: carpal and cubital tunnel explained

Hand numbness and tingling can come from different problems. Correct diagnosis matters because carpal tunnel and cubital tunnel affect different nerves and need different treatments. Seek care if symptoms last or cause weakness.

Level

Read

26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.

Level

Read

No more articles